FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892328325> ?p ?o ?g. }

• W2892328325 endingPage "33" @default.
• W2892328325 startingPage "26" @default.
• W2892328325 abstract "Angiogenesis is fundamental for solid tumor growth and metastasis, and anti-angiogenic therapy has been an important therapeutic option for cancer treatment. Colorectal cancer (CRC) represents the fourth leading cause of cancer-related death worldwide. The current studies were aimed at investigating the anti-angiogenic effects of the natural compound 4′-hydroxywogonin (4′-HW) on CRC-related angiogenesis. Human CRC cell line SW620 cells and normal human intestinal epithelial HIEC cells were cultured and treated with interleukin-6 to mimic the tumor inflammatory microenvironment. Our data showed that 4′-HW reduced the viability of SW620 cells in a concentration- and time-dependent manner. 4′-HW also suppressed the proliferation of SW620 cells, but had little effect on the viability of HIEC cells. Moreover, 4′-HW concentration-dependently decreased the mRNA and protein expression of vascular endothelial growth factor-A (VEGF-A), the predominant pro-angiogenic cytokine in tumor angiogenesis. Subsequently, 4′-HW concentration-dependently inhibited the phosphorylation of phosphatidylinositol 3-kinase (PI3K) and AKT. PI3K inhibitor wortmannin, similar to 4′-HW, significantly downregulated the VEGF-A expression in SW620 cells, and combination of wortmannin and 4′-HW produced more significant effects. Finally, human umbilical vein endothelial cells (HUVECs) incubated with the conditioned medium of 4′-HW-treated SW620 cells exhibited impaired angiogenic capacity at Matrigel. Incubation with the neutralizing antibody against VEGF-Aalone also suppressed the angiogenic properties of HUVECs in vitro. Collectively, 4′-HW decreased the viability and reduced angiogenesis in CRC, which was associated with downregulation of VEGF-A expression by disrupting the PI3K/AKT pathway. Our discoveries suggested 4′-HW as a promising anticancer agent against CRC targeting angiogenesis." @default.
• W2892328325 created "2018-09-27" @default.
• W2892328325 creator A5028828620 @default.
• W2892328325 creator A5032161199 @default.
• W2892328325 creator A5041388825 @default.
• W2892328325 creator A5044695121 @default.
• W2892328325 creator A5052274720 @default.
• W2892328325 creator A5057266089 @default.
• W2892328325 creator A5064827774 @default.
• W2892328325 creator A5071915668 @default.
• W2892328325 creator A5073521504 @default.
• W2892328325 creator A5088797877 @default.
• W2892328325 date "2018-12-01" @default.
• W2892328325 modified "2023-10-15" @default.
• W2892328325 title "4′-hydroxywogonin inhibits colorectal cancer angiogenesis by disrupting PI3K/AKT signaling" @default.
• W2892328325 cites W1981725448 @default.
• W2892328325 cites W2020136936 @default.
• W2892328325 cites W2039010667 @default.
• W2892328325 cites W2040876612 @default.
• W2892328325 cites W2041757389 @default.
• W2892328325 cites W2042204791 @default.
• W2892328325 cites W2046493675 @default.
• W2892328325 cites W2054884455 @default.
• W2892328325 cites W2055253966 @default.
• W2892328325 cites W2120377313 @default.
• W2892328325 cites W2146383172 @default.
• W2892328325 cites W2148939957 @default.
• W2892328325 cites W2295851099 @default.
• W2892328325 cites W2326378504 @default.
• W2892328325 cites W2465561570 @default.
• W2892328325 cites W2563813027 @default.
• W2892328325 cites W2592234220 @default.
• W2892328325 cites W2608179723 @default.
• W2892328325 cites W2719499442 @default.
• W2892328325 cites W2731227355 @default.
• W2892328325 cites W2742691451 @default.
• W2892328325 cites W2743906406 @default.
• W2892328325 cites W2753307220 @default.
• W2892328325 cites W2765725361 @default.
• W2892328325 cites W2769954443 @default.
• W2892328325 cites W2791843165 @default.
• W2892328325 doi "https://doi.org/10.1016/j.cbi.2018.09.003" @default.
• W2892328325 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30217479" @default.
• W2892328325 hasPublicationYear "2018" @default.
• W2892328325 type Work @default.
• W2892328325 sameAs 2892328325 @default.
• W2892328325 citedByCount "16" @default.
• W2892328325 countsByYear W28923283252019 @default.
• W2892328325 countsByYear W28923283252020 @default.
• W2892328325 countsByYear W28923283252021 @default.
• W2892328325 countsByYear W28923283252022 @default.
• W2892328325 countsByYear W28923283252023 @default.
• W2892328325 crossrefType "journal-article" @default.
• W2892328325 hasAuthorship W2892328325A5028828620 @default.
• W2892328325 hasAuthorship W2892328325A5032161199 @default.
• W2892328325 hasAuthorship W2892328325A5041388825 @default.
• W2892328325 hasAuthorship W2892328325A5044695121 @default.
• W2892328325 hasAuthorship W2892328325A5052274720 @default.
• W2892328325 hasAuthorship W2892328325A5057266089 @default.
• W2892328325 hasAuthorship W2892328325A5064827774 @default.
• W2892328325 hasAuthorship W2892328325A5071915668 @default.
• W2892328325 hasAuthorship W2892328325A5073521504 @default.
• W2892328325 hasAuthorship W2892328325A5088797877 @default.
• W2892328325 hasConcept C121608353 @default.
• W2892328325 hasConcept C126322002 @default.
• W2892328325 hasConcept C167734588 @default.
• W2892328325 hasConcept C203014093 @default.
• W2892328325 hasConcept C2777025900 @default.
• W2892328325 hasConcept C2778308172 @default.
• W2892328325 hasConcept C2779013556 @default.
• W2892328325 hasConcept C2780394083 @default.
• W2892328325 hasConcept C502942594 @default.
• W2892328325 hasConcept C62478195 @default.
• W2892328325 hasConcept C71924100 @default.
• W2892328325 hasConcept C75217442 @default.
• W2892328325 hasConcept C86554907 @default.
• W2892328325 hasConcept C86803240 @default.
• W2892328325 hasConcept C95444343 @default.
• W2892328325 hasConceptScore W2892328325C121608353 @default.
• W2892328325 hasConceptScore W2892328325C126322002 @default.
• W2892328325 hasConceptScore W2892328325C167734588 @default.
• W2892328325 hasConceptScore W2892328325C203014093 @default.
• W2892328325 hasConceptScore W2892328325C2777025900 @default.
• W2892328325 hasConceptScore W2892328325C2778308172 @default.
• W2892328325 hasConceptScore W2892328325C2779013556 @default.
• W2892328325 hasConceptScore W2892328325C2780394083 @default.
• W2892328325 hasConceptScore W2892328325C502942594 @default.
• W2892328325 hasConceptScore W2892328325C62478195 @default.
• W2892328325 hasConceptScore W2892328325C71924100 @default.
• W2892328325 hasConceptScore W2892328325C75217442 @default.
• W2892328325 hasConceptScore W2892328325C86554907 @default.
• W2892328325 hasConceptScore W2892328325C86803240 @default.
• W2892328325 hasConceptScore W2892328325C95444343 @default.
• W2892328325 hasFunder F4320321001 @default.
• W2892328325 hasFunder F4320322769 @default.
• W2892328325 hasFunder F4320327518 @default.
• W2892328325 hasLocation W28923283251 @default.
• W2892328325 hasLocation W28923283252 @default.

• next